Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
07/2012
07/25/2012CN102603610A 1,3-dihydro-1-oxo-2H-isobenzazole compounds as well as preparation method and use thereof
07/25/2012CN102600416A Chinese medicinal preparation for treating obstructed eustachian tube and earache in cold weather
07/25/2012CN102600386A Chinese herba preparation for treating eye inflammation and preparation method of Chinese herba preparation
07/25/2012CN102600356A Composition for improving vision and preparation method
07/25/2012CN102600334A Traditional Chinese preparation for treating obstruction of auditory tube and ear pain symptom under warm climate condition
07/25/2012CN102600300A Externally-applied liquid medicine for treatment of pinkeye and preparation method thereof
07/25/2012CN102600235A Chinese medicinal eye drop for treating oculopathy
07/25/2012CN102600163A Ophthalmic and otic compositions of facially amphiphilic polymers and oligomers and uses thereof
07/25/2012CN102600115A Application of curcumin C and derivative C3 thereof in preparing medicine for preventing macular degeneration of retina
07/25/2012CN102600050A Eye-protecting health care patch with self-heating steam and nutrition
07/25/2012CN102274281B Chinese medicine detoxifying powder for treating tympanitis
07/25/2012CN102228580B Chinese herbal composition for treating sudden deafness
07/25/2012CN102198258B Method for preparing Chinese medicine for treating kidney-yin deficiency tympanitis
07/25/2012CN102198227B Method for preparing Chinese medicine for treating yin-deficiency glaucoma
07/25/2012CN102188675B Medicine for treating peripheral vertigo, and preparation thereof
07/25/2012CN102078614B Method for inhibiting shortsightedness and application of adenylate cyclase inhibitor as medicament for inhibiting shortsightedness
07/25/2012CN101987166B Medicament for treating stye and preparation method thereof
07/25/2012CN101912355B Recombinant human interleukin-1 receptor antagonist in-situ gel
07/25/2012CN101732506B External oculentum for treating amblyopia, astigmatism, strabismus, myopia and visual fatigue of teenagers
07/25/2012CN101716255B Medicinal composition with function of protecting optic nerve and preparation method and application thereof
07/25/2012CN101554369B External spraying agent and eye drop of compound oil nano-emulsion as well as preparation method thereof
07/24/2012US8227620 Pharmaceutical compounds
07/24/2012US8227474 Sodium channel blockers
07/24/2012US8227200 Methods for identifying kremen polypeptide binding partners
07/24/2012CA2476065C Inhibitors of histone deacetylase
07/24/2012CA2471822C Cell-specific herpes simplex virus expression/replication vector comprising icp4 and human calponin gene promoter
07/24/2012CA2458146C Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection
07/24/2012CA2438334C Ocular tear growth factor-like protein
07/19/2012WO2012097019A1 Use of a vegf antagonist to treat angiogenic eye disorders
07/19/2012WO2012095836A1 Anti-angiogenic compound
07/19/2012WO2012095525A1 Composition comprising opc and omega-3 for preventing and/or inhibiting the development of diabetic retinopathy
07/19/2012WO2012068998A3 Triamcinolone acetonide ophthalmic preparation and preparation method thereof
07/19/2012WO2012068549A3 Therapeutic agent formulations for implanted devices
07/19/2012WO2012065106A3 Compounds and related methods for manipulating parp-1-dependent cell death
07/19/2012WO2012004631A3 Recombinant antibody structures binding to and blocking the activity of vascular endothelial growth factor 2 (vegfr- 2 /kdr)
07/19/2012US20120184620 Antioxidant composition
07/19/2012US20120184612 Compositions and Methods Relating to Carotenoids
07/19/2012US20120184599 Use of MicroRNA for Treating Diseases Associated with a Dysfunction of the Cilia in Multiciliated Epithelial Cells
07/19/2012US20120184585 Fatty acid niacin conjugates and their uses
07/19/2012US20120184583 Modulators of atp-binding cassette transporters
07/19/2012US20120184569 A3 adenosine receptor agonists and antagonists
07/19/2012US20120184565 Compounds for the reduction of beta-amyloid production
07/19/2012US20120184552 Latanoprost-containing aqueous eye drops and method for inhibiting adsorption of latanoprost to resin
07/19/2012US20120184551 Combination of brimonidine and timolol for topical ophthalmic use
07/19/2012US20120184523 C-Met Modulators and Method of Use
07/19/2012US20120184511 Novel Pharmaceutical Composition Comprising a Macrolide Immunosuppressant Drug
07/19/2012US20120184496 Ophthalmic pharmaceutical compositions of dp2 receptor antagonists
07/19/2012US20120184484 Lactoferrin and brain health and development in infants
07/19/2012US20120184481 Variants of pigment epithelium derived factor and uses thereof
07/19/2012US20120183593 Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases
07/19/2012US20120183565 Fully human antibodies to btla
07/19/2012US20120183549 Chemokine receptor binding polypeptides
07/19/2012US20120183543 Diagnostic biomarkers for fibrotic disorders
07/19/2012US20120183523 Methods and Compounds for Promoting Vessel Regression
07/19/2012CA2824422A1 Use of a vegf antagonist to treat angiogenic eye disorders
07/19/2012CA2823607A1 Composition comprising opc and omega-3 for preventing and/or inhibiting the development of diabetic retinopathy
07/18/2012EP2476682A1 8-oxodihydropurine derivative
07/18/2012EP2476678A1 Substituted carbonyl compounds
07/18/2012EP2476425A1 Composition comprising OPC and Omega-3 for preventing and/or inhibiting the development of diabetic retinopathy
07/18/2012EP1884234B1 Prophylactic or therapeutic agent for corneal and conjunctival disorder
07/18/2012EP1470148B1 Double-stranded oligonucleotides
07/18/2012CN1935260B Human antibodies that bind human tnfalpha
07/18/2012CN1440408B Inhibitors of human phosphatidyl-inositol 3-kinase delta
07/18/2012CN102596949A 8-azabicyclo[3.2.1]octane-8-carboxamide derivative
07/18/2012CN102596929A Treatment of macular degeneration
07/18/2012CN102596917A Disaccharin, difumaric acid, di-l-hydroxy-2-naphthoic acid and mono-benzoic acid salts of 4- (dimethylamin0)butyl 2- (4- ( (2-amino-4-methyl-6- (pentylamino) pyrimidin- 5 -yl) methyl) phenyl)acetate
07/18/2012CN102596199A Ophthalmic pharmaceutical compositions of DP2 receptor antagonists
07/18/2012CN102586377A Concentrate containing carotenoid monomer and preparation method as well as application thereof
07/18/2012CN102586300A Polyamide amine, part degradation product or complex of polyamide amine-Math1 gene nano microparticles and application of gene nano microparticles in treating deafness
07/18/2012CN102586174A Pluripotent cell derived from cataract mouse model, its preparation method and application
07/18/2012CN102584954A Protein for treating blood vessel hyperplasia of eyes
07/18/2012CN102584949A Pc-C polypeptide inhibiting aspergillus fumigatus from adhering to cornea
07/18/2012CN102580069A Eye-drop vaccine containing copolymer 1 for therapeutic immunization
07/18/2012CN102580039A Traditional Chinese medicine for treating glaucomatocy clitic crisis syndrome and preparation method
07/18/2012CN102579991A Chinese medicinal inflammation diminishing preparation for treating herpes simplex keratitis
07/18/2012CN102579965A Preparation method of medicinal navel-applied plaster for treating giddiness
07/18/2012CN102579918A Traditional Chinese medicine composition for treating glaucoma as well as preparation method and administration mode of same
07/18/2012CN102579844A Medicine for treating Meniere's disease
07/18/2012CN102579840A Chinese medicinal composition with effects of reducing intraocular pressure and protecting optic nerves and preparation method thereof
07/18/2012CN102579778A Traditional Chinese medicine for treating Behcet disease and Behcet syndrome
07/18/2012CN102579724A Chinese medicine composition for treating glaucoma
07/18/2012CN102579723A Chinese medicine preparation method for treating pus ears
07/18/2012CN102579701A Compound dandelion decoction
07/18/2012CN102579600A Method for preparing decumbent corydalis tuber eye drop and product
07/18/2012CN102579599A Decumbent corydalis tuber eye drop and preparation method thereof
07/18/2012CN102579543A Method for extracting Chinese medicinal active ingredients of marigold inflorescences
07/18/2012CN102579492A Sodium hyaluronate eyedrop containing deproteinized calf blood extractive and preparation method thereof
07/18/2012CN102579469A Application of ascorbic acid glucoside
07/18/2012CN102579452A Preparation method of tryptanthrin compound and new application of tryptanthrin compound in preparing indoleamine-2,3-dioxygenase (IDO) inhibitor
07/18/2012CN102579335A Azithromycin eye drops
07/18/2012CN102579321A Tinidazole ophthalmic gel, and preparation method and application thereof
07/18/2012CN102178923B Preparation method of traditional Chinese medicament for treating swelling tympanitis in external auditory meatus
07/18/2012CN102008439B Curcumin coated liposome preparation and preparation method thereof
07/18/2012CN101926762B Rupatadine fumarate eye drops and preparation method thereof
07/18/2012CN101880283B Azaindole kinase inhibitors
07/18/2012CN101851238B Substituted 8-heteroaryl xanthines
07/18/2012CN101019967B Process of preparing antiviral medicine composition
07/17/2012US8222277 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
07/17/2012US8222231 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
07/17/2012US8221794 Anti-angiogenic nanoparticle compositions
1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 531